title: Nicotinic acid treatment for Paralepistopsis acromelalga intoxication: assessment using magnetic resonance imaging.
abstract: BACKGROUND
  Paralepistopsis acromelalga, formerly known as Clitocybe acromelalga, is a rare poisonous mushroom. The mycotoxins in this mushroom cause symptoms resembling those of erythromelalgia; however, its pathogenesis remains unclear. In this report, a patient who received nicotinic acid treatment for P. acromelalga poisoning and radiological evaluation for erythromelalgia has been presented. Case detail: A 59-year-old woman was hospitalized for redness, swelling, and burning pain in her extremities that rendered difficulty in walking, and a diagnosis of P. acromelalga poisoning was made by detailed interview and mushroom identification. She was treated with intravenous nicotinic acid for 17 days followed by oral nicotinic acid amide for 2 months. She exhibited rapid symptomatic improvement and walked independently after 11 days of initial treatment. Initial MRI of her feet revealed toe-dominated subcutaneous thickening. After nicotinic acid treatment, those radiological findings improved dramatically.
  
  
  CONCLUSIONS
  The subcutaneous thickening evident on MRI indicated P. acromelalga poisoning-induced erythromelalgia involved subcutaneous inflammatory edema. The typical duration of edema without treatment is more than a month. The improvement on MRI after nicotinic acid treatment indicated that the adequate vasodilation induced by nicotinic acid contributed to resolution of the symptoms. Nicotinic acid was associated with the improvement of the edematous changes caused by the P. acromelalga intoxication.
authors.affiliation: a Department of Neurology , Kitamurayama Hospital , Yamagata , Japan ;
authors.forename: Nobuhito
authors.initials: N
authors.lastname: Nakajima
authors.affiliation: b Department of Neurology and Stroke Medicine , Tokyo Metropolitan Tama Medical Center , Tokyo , Japan.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Ueda
mesh_terms: D061605:Administration, Intravenous; D000363:Agaricales; D004305:Dose-Response Relationship, Drug; D004916:Erythromelalgia / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006760:Hospitalization; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D009145:Mushroom Poisoning / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D009183:Mycotoxins / Q000506:poisoning*; D009525:Niacin / Q000627:therapeutic use*
chemical_list: D009183:Mycotoxins; D009525:Niacin
keywords: Erythromelalgia; magnetic resonance imaging; mushroom poisoning